Eligibility Prostate Cancer NCT00269555

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
participants must be male and have a pathological diagnosis of prostate cancer.
Beschrijving

Gender | Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0600139
no treatment (surgery [rrp], radiation, or hormones) prior to study entry.
Beschrijving

Therapeutic procedure | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
UMLS CUI [2]
C0543467
UMLS CUI [3]
C0194825
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0279025
the patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery [rrp], radiation, or hormones) for the next six months.
Beschrijving

Patient Decision | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0679006
UMLS CUI [2]
C0543467
UMLS CUI [3]
C0194825
UMLS CUI [4]
C1522449
UMLS CUI [5]
C0279025
psa between 2.0 and 10.0 ng/ml.
Beschrijving

Prostate specific antigen measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0201544
if psa is >10.0, patient must have been on active surveillance for 12 months prior to study initiation.
Beschrijving

Raised prostate specific antigen | Patient Surveillance Duration

Datatype

boolean

Alias
UMLS CUI [1]
C0178415
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0038842
UMLS CUI [2,3]
C0449238
no known allergy to soy or soy products.
Beschrijving

Allergy to soy | Hypersensitivity Soy product

Datatype

boolean

Alias
UMLS CUI [1]
C4075590
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1532456
the patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (otc supplements).
Beschrijving

Genistein Unit per Gram per Day Dietary Supplements

Datatype

boolean

Alias
UMLS CUI [1,1]
C0061202
UMLS CUI [1,2]
C2349072
UMLS CUI [1,3]
C0242295
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
no pathological documentation of prostate cancer.
Beschrijving

Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0600139
allergy to soy or soy products
Beschrijving

Allergy to soy | Hypersensitivity Soy product

Datatype

boolean

Alias
UMLS CUI [1]
C4075590
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1532456
prior history of treatment for prostate cancer.
Beschrijving

Therapeutic procedure Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0600139

Similar models

Eligibility Prostate Cancer NCT00269555

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Prostate carcinoma
Item
participants must be male and have a pathological diagnosis of prostate cancer.
boolean
C0079399 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
Therapeutic procedure | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
no treatment (surgery [rrp], radiation, or hormones) prior to study entry.
boolean
C0087111 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Patient Decision | Operative Surgical Procedures | Radical retropubic prostatectomy | Therapeutic radiology procedure | Hormone Therapy
Item
the patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery [rrp], radiation, or hormones) for the next six months.
boolean
C0030705 (UMLS CUI [1,1])
C0679006 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0194825 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
Prostate specific antigen measurement
Item
psa between 2.0 and 10.0 ng/ml.
boolean
C0201544 (UMLS CUI [1])
Raised prostate specific antigen | Patient Surveillance Duration
Item
if psa is >10.0, patient must have been on active surveillance for 12 months prior to study initiation.
boolean
C0178415 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0038842 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Allergy to soy | Hypersensitivity Soy product
Item
no known allergy to soy or soy products.
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Genistein Unit per Gram per Day Dietary Supplements
Item
the patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (otc supplements).
boolean
C0061202 (UMLS CUI [1,1])
C2349072 (UMLS CUI [1,2])
C0242295 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Prostate carcinoma
Item
no pathological documentation of prostate cancer.
boolean
C0600139 (UMLS CUI [1])
Allergy to soy | Hypersensitivity Soy product
Item
allergy to soy or soy products
boolean
C4075590 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C1532456 (UMLS CUI [2,2])
Therapeutic procedure Prostate carcinoma
Item
prior history of treatment for prostate cancer.
boolean
C0087111 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])